Diligence & Business Strategy

Whether you are a company seeking funding or an investor considering an investment in the CGT space, DHC has the expertise to support your needs. Our most common offerings in the area of Diligence & Business Strategy (formerly known as Financing and Diligence) include:

Due diligence technical assessments

We are frequently called upon by investors to perform due diligence on companies in the Cell and Gene Therapy space. Alternatively, for companies seeking investment, our mock diligence service can help ensure you are prepared for questions investors may raise.

Landscape scanning

Our knowledge of the Cell and Gene Therapy landscape can help you identify investment targets that are well-aligned with your portfolio objectives.

Teach-ins

Are you an experienced investor who is new to the complex world of cell and gene? Or an existing pharma or biotech company that has recently acquired a cell and gene asset? We provide customized CGT teach-ins.

Message optimization and market positioning

Our unique combination of deep technical expertise and investor relations experience allows us to provide a candid assessment of your program and strategic planning for an optimal ‘pitch.’

Other Core Capabilities

DHC Experts in

Diligence & Business Strategy

In need of a business consult?

We're here to help.
Request Consultation
Text Link
Facilities, Manufacturing, & Compliance
Text Link
Clinical Regulatory
Text Link
Diligence & Business Strategy
Text Link
Market Expertise
Text Link
Quantitative Modeling
Text Link
Project & Program Management
Text Link
Nonclinical Development
Text Link
Regulatory Affairs
Text Link
Facility Design & Engineering
Text Link
Quality Assurance
Text Link
Manufacturing Operations
Text Link
Device Development
Text Link
Analytical Development
Text Link
Product & Process Development